At a time when domestic generic medicines are helping the developed world to slash healthcare costs, big pharma has lashed out at indian manufactruers. The remarks made by chairman of one of the world’s largest companies, Sanofi Aventis, attacking domestic generic companies for exporting drugs, has created a furore.
Infuriated, the industry has asked the government to step in and register their protest at an appropriate forum.
Recently, Jean-Francois Dehecq, chairman of French firm Sanofi-Aventis, citing India as an example has criticised generic companies for exporting drugs rather than selling them locally. He’s been reported as saying in the media, “They make (drugs) cheaply and bring them to the North for people who can already pay. It is a scandal. They are exploiting people in the South. They should deal with their own countries first.”
Indian Pharmaceutical Alliance secretary general, DG Shah, told Times of India: “This statement is indicative of the mindset of the big pharma that the third world nations should not look at them for access to medicine. It conveys a message to the trade negotiators that the developing countries like India, Brazil and Indonesia should not look at the West as a market for their generic products.”
The industry has countered the charges saying that they are baseless. It has said in a letter to the commerce secretary that the domestic industry has not only made indian manufacturer self-sufficient for most of its medicines requirement but also emerged as a major source of supply for the developing countries. Such statements, if not challenged, hurt the interest of the domestic industry, it adds.
One of the major generic manufacturers, Cipla’s joint MD Amar Lulla said “This (statement) reflects the insecurity of the big pharma towards India.” Generic drugs are copies of patented medicines and are sold in certain cases at even onetenth of the prices of the branded but offpatent drugs.
The domestic industry wants to sensitise government to the attitude of the big pharma, whom it wants to “please through a trade related aspects of intellectual property rights plus IPR regime.” Sanofi-Aventis has two manufacturing units in India, both of which have been identified as global sourcing units, and its Indian operations recorded export revenues of 30% of its total sales in 2005
Indian generic companies lash out at US pharma biggie
Saturday, 31 August 2013
Labels:
Exporters,
Importers,
manufacturer,
Manufacturers,
Products,
service providers,
supplier,
suppliers,
Trade Leads
brass hardware manufacturers
Friday, 30 August 2013
business services directory
SEMCOM, CVMs premiere business college takes business to a new level by offering innovative Master of E-Business degree. The programme combines marketing andbusiness dynamics with special IT training to make the student candidate a competent E-business enabled professional who can blend new age business initiatives and use the power of IT, internet and WiFi technology to increase customer base, maintain inventory, perform HR works across geographic distances, reach new markets, design innovative product promotion and use digital entrepreneurship to increase company productivity. The classroom has eminent experts like Pavan Duggal holding discussions, regular case studies and presentations, one of a kind Cyber law clinic, holding E-Business summit search engine optimisation, ethical hacking and industry internship programmes. SEMCOM also offers a 4-year BBA (Hon.) in IT Management offering dual specialisation in HR, Marketing, Management, Advanced ERP and International business. business services directory The standard 3-year BBA (General) focuses on Marketing management, financial management, exports management with practical studies. Admission to both is through a competitive test. The BCA program offers specialised overview of IT, Software engineering, System analysis, Database management etc. The BCom (General) course offers specialisations in accountancy and management. CZ Patel College of Business and Management CZ Patel College of Business and Management offers 4-year BBA(Hons) in Hospitality Management, Travel and Tourism Management and BCom (Hons) in Corporate Banking, International Accounting and Insurance. It is also offering strategic collaboration with Myers University USA and Malaspina University Canada in partnership with University of Hertfordshire UK to offer a dual degree of MBA and MSc (International Business) to BBA and BCom students. Students also get to go on study tours to events and trade shows in Singapore or Dubai to gain on hand experience. Graduates from CZ Patel College are directly eligible for admission in MBA programs of the foreign universities. The college has also tied up with Asian American Hotel Owners Association (AAHOA), USA to act as a collaborating body for internships and final placements for students to top-notch hospitality providers around the world. Leading experts from the field of insurance, banking and financial management come to interact with students of BCom (Hons) in Corporate Banking, International Accounting and Insurance. Career opportunities have moved to create new niche jobs as investment analysts, management consultants, corporate governance, public sector finance, HR Managers etc. Students get an insight service providers from India
into Business Law, Accounting and Auditing, Fundamentals of Banking and Insurance and are regularly taken on field visits and internship placements. business consulting firms
apparel manufacturer
Thursday, 29 August 2013
Dhanteras is the time when retail fraternity is waiting with open arms to welcome shoppers and satiate their whims, fancies and tastes. Delhi's markets have indeed come of age and are now self-contained. Offering a plethora of options, you can buy anything and everything at the posh Delhi markets.
Visit any of the city markets and you are sure to come across the sight of chattering women and children dressed up in their very best, shopping for the much awaited festival of the year. Excitement and fervour can be seen everywhere with markets booming and joining in the festivities. However, the series of bomb blasts and probably a dip in Sensex has made few residents apprehensive who prefer to keep away from indulgence. But there are other enthusiasts who are flocking these markets undeterred to get their hand on the very best of decoratives. Ranging from fluorescent decorative lights and Laxmi-Ganesh idols to streamers and flowers, a variety of everything is available in these markets.
Malls have become the latest shoppers paradise. People flock in at these malls in huge numbers, as these malls provide them ample options under one roof. Be it clothes, jewellery, lifestyle products or food, there is something for everybody. Places like Gurgaon, Noida, East Delhi, Ghaziabad and Rajouri Garden bear testimony to the fact that malls have now become a one-stop-shopping solution for those who are short of time but do not want to be short strapped of creative ideas.
HOUSEHOLD ITEMS
Dhanteras, traditionally associated with buying of utensils is still followed with religious sanctity by many families. To cater to these demands, Delhi shops offer an array of conventional items as well as contemporary and utility household goods which both serve their religious and traditional purpose as well as make a good utility item. Kitchenwares can be bought from shops at Karol Bagh and Connaught Place. But if you are looking at
wholesale apparel manufacturers, then Wazirpur and Sadar Bazaar is the place you should head to. The markets offer a wide range in terms of steel and other metal utensils.
SAREES, BRANDED GARMENTS
Head straight to market places like Chandani Chowk, Rajouri Garden, Tilak Nagar, Lajpat Nagar or South Extention if you are looking for traditional ethnic clothes, or branded apparel manufacturer. Here you can find the most stylish as well as in-vogue patterns that are sure to grab some eye-balls.
ELECTRONIC GIZMOS
Want to compare prices, brands and models of the latest electronic gizmos or white goods? Bhagirath Palace (near Chandani Chowk) is where you will find everything you ever wanted in terms of electronics. Gaffar Market in Karol Bagh and Palika Bazaar, Nehru Place are other places that promise to fulfil your gizmo appetite.
GOLD AND JEWELLERY
Jewellery is still synonymous with places like Dariba Kalan in Chandni Chowk or Bank Street in Karol Bagh. Though there are various other jewellery shops that have sprung up in Delhi recently that have really dazzled the female population here and made the menfolk loosen their purse strings. Jewellery shops that have recently caught the fancy of buyers are South Extension, Tilak Nagar and Pitam Pura. apparel manufacturers india
GIFT ARTICLES
'Gifting' is a simple concept, yet choosing the right gift can mean so much. It can show personalized affection, care and understanding of the receiver's likes and dislikes, small things that do not go unnoticed. Thus while choosing a gift for the joyous moment, give your gifts a personal touch too. And luckily for you discerning shoppers, there is ample choice. Be it crystal, crockery, cutlery, leather items or even a gift, you can be assured that your memento would stand out in the assorted crowd.
Now that you know what to buy from and where, all you need is loads of money to make the most of this festive season. Happy shopping
automobiles manufacturers
While buoyancy in vehicle sales in India may be heartening for the industry and economy, it is also leading to a rise in road accident fatalities in the country. automobile manufacturers in india has the dubious distinction of being the second highest in the world after China in annual road accident fatalities.
The number of annual road accident fatalities in India crossed the 80,000 mark in 1999 — a rising trend since 1990 when the number was 54,000 as per the department of road transport and highways data.
In 2002, the number of road accident fatalities per 10,000 vehicles was the highest in China (17.10) followed by India (14.39). In most highincome countries such as Sweden, US, Australia, Japan and Germany it ranged between 1.08 and 2.58.
While globally 90% of road crashes were attributed to “human error” by the World Health Organisation’s “World report on road traffic injury prevention”, in India “driver fault” was to blame for 83.5% of accidents, followed by passenger/pedestrian fault (4.7%), mechanical defect in vehicles (3%) and “other factors” (6.8%) such as cattle, fallen trees, non-functional signals and absence of reflectors.
These were some details highlighted in a study published by Pune-based Central Institute of Road Transport’s (CIRT) latest edition of the Indian Journal of Transport Management. automobile supplies
Society of Indian automobiles manufacturers (Siam) said sale of passenger cars in India rose by 69.23% between 2001-2005 — from 5.67 lakh in 2000-01 to 8.19 lakh in 2004-05. Siam statistics state sale of two wheelers rose by 58% during the same period, with domestic sales of two wheelers rising from 3.6 million in 2000-01 to 6.2 million in 2004-05.
Based on the WHO report, the study by Alok Rawat, principal secretary with the Sikkim government notes the social cost of road accidents in the country was pegged at Rs 55,000 crore in 1999-2000, constituting 3% of the Gross Domestic Product (GDP) for that year.
Although road accidents have been traditionally viewed as random events “that happen to others”, according to Rawat, the new paradigm shift now views road crashes as “preventable and predictable.”
This has been demonstrated in high income countries, says Rawat, where an established set of interventions through legislations and technology have led to “significant reductions in the incidence and impact of road traffic injuries.”
agricultural products manufacturers
Life’s Good” for LG India head Soon Kwon but he wishes the economy were in better health.
Kwon, 55, believes that to beat the slowdown there is a need to engage a large part of the population in industriali zation. According to heavy dependence on agricul ture, and even FDI, is not right way forward if wants to return to a higher growth trajectory and, importantly, match up to China.
The slowdown has already made Korean consumer giant LG Electronics rethink some of its planned investments for India. “Regarding new investments for plant and manufacturing, we would have to make necessary adjustments,” says Kwon, who has had stints at the company’s headquarters in South Korea apart from Australia, US and Canada.
“The first months of this year were more encouraging than last year. During the initial months last year, everybody was worried about the overall macro-economic situation, mostly the rupee value. But now that the rupee is slowly stabilizing, LG feels a little better in the overall business sense,” says Kwon.
Kwon feels the government should put more emphasis on industrialization as “India’s growth rate has fallen drastically and this has had an effect on the overall economy”. “The dependency on agriculture and FDI is too high. Until we have a global industrialization plan, I cannot see how it will be possible to achieve an economic growth rate of 8-9%. As a
Agricultural products manufacturers, we want to see some radical and rational moves towards industrialization.”
Agricultural equipments manufacturers
He says that the poor economic performance is having an effect on how corporates view India. “Disposable incomes are not rising even though the prices of products are. Three or four years ago, everyone expected consumer demand to double in the next five years, but it seems like demand is falling,” Kwon says.
LG has four major business divisions in India – television, home appliances, air conditioners and mobile phones. Home appliances contribute about 50% to its revenues, TVs about 35%, ACs 10% and mobiles chip in the least. Is the company worried that mobiles form a small portion of its business, especially considering that most of its competitors like Samsung and Sony bank so much on the mobile phone business? “Different companies may have different business portfolios. They may be more successful than us in mobiles but LG is obviously the leader in other segments,” Kwon says.
LG is globally re-working its strategy on mobile phones. “The whole mobile business mechanism is more dynam- than other segments, and it is also a very global business. Last year, we shifted our mobile priorities and decided to pull out of lower-budget phones, and instead focus on smartphones. Ever since then, our mobile business has started growing. This year, we can grow it to 10% of our over- business,” Kwon says.
Apart from a sluggish , corporates in India – including LG – have been having a run-in with tax authorities. “I do not think that this will impact our business at all… I do think that the government should spend more time in allocating resources for industrialization. I do not know to what scale the government would go further, but this tax issue is a worrying factor.” agricultural products exporters
Kwon feels that the government needs to come out with policies that aid corporate growth, which is a necessary step to compete against China. “If you look at the global market, India may be the only country to ultimately compete against China. The role of the Indian government is very important here as the economy does not grow on its own... how to grow further and how to reduce the gap between India and China will depend on how we grow in the industrial sector.”
When he is not slugging it out in the Indian market for business, Kwon loves to play guitar and join his wife for shopping. Having spearheaded the India operations of LG for the past two years, Kwon has also developed a taste for Indian food, which is evident from his fondness for chicken tikka and naan
automobiles manufacturers
While buoyancy in vehicle sales in India may be heartening for the industry and economy, it is also leading to a rise in road accident fatalities in the country. automobile manufacturers in india has the dubious distinction of being the second highest in the world after China in annual road accident fatalities.
The number of annual road accident fatalities in India crossed the 80,000 mark in 1999 — a rising trend since 1990 when the number was 54,000 as per the department of road transport and highways data.
In 2002, the number of road accident fatalities per 10,000 vehicles was the highest in China (17.10) followed by India (14.39). In most highincome countries such as Sweden, US, Australia, Japan and Germany it ranged between 1.08 and 2.58.
While globally 90% of road crashes were attributed to “human error” by the World Health Organisation’s “World report on road traffic injury prevention”, in India “driver fault” was to blame for 83.5% of accidents, followed by passenger/pedestrian fault (4.7%), mechanical defect in vehicles (3%) and “other factors” (6.8%) such as cattle, fallen trees, non-functional signals and absence of reflectors.
These were some details highlighted in a study published by Pune-based Central Institute of Road Transport’s (CIRT) latest edition of the Indian Journal of Transport Management. automobile supplies
Society of Indian automobiles manufacturers (Siam) said sale of passenger cars in India rose by 69.23% between 2001-2005 — from 5.67 lakh in 2000-01 to 8.19 lakh in 2004-05. Siam statistics state sale of two wheelers rose by 58% during the same period, with domestic sales of two wheelers rising from 3.6 million in 2000-01 to 6.2 million in 2004-05.
Based on the WHO report, the study by Alok Rawat, principal secretary with the Sikkim government notes the social cost of road accidents in the country was pegged at Rs 55,000 crore in 1999-2000, constituting 3% of the Gross Domestic Product (GDP) for that year.
Although road accidents have been traditionally viewed as random events “that happen to others”, according to Rawat, the new paradigm shift now views road crashes as “preventable and predictable.”
This has been demonstrated in high income countries, says Rawat, where an established set of interventions through legislations and technology have led to “significant reductions in the incidence and impact of road traffic injuries.”
indian manufacturers
Monday, 26 August 2013
Labels:
b2b business directory,
exporter,
Exporters,
Importer Directory,
Importers,
manufacturer,
Manufacturers,
Products,
service providers,
supplier,
suppliers,
Trade Leads,
yellow pages of Indian
indian manufacturer
Labels:
b2b business directory,
exporter,
Exporters,
Importer Directory,
Importers,
manufacturer,
Manufacturers,
Products,
service providers,
supplier,
suppliers,
Trade Leads,
yellow pages of Indian
chemicals manufacturers
Saturday, 24 August 2013
business consulting firms
business consulting firms
Friday, 23 August 2013
service providers from India
Wednesday, 21 August 2013
business services directory
business consulting firms
business services directory
Tuesday, 20 August 2013
agricultural products manufacturers
Saturday, 17 August 2013
brass hardware manufacturers
automobiles manufacturers
apparel manufacturer
computer manufacturer
indian manufacturer
What are your views on the penalty to Ranbaxy and do you believe the $500 million payout was too harsh?
It’s unfortunate. The company lost over $500 million in business opportunities, which may be the highest for any generic company, but the Food and Drug Administration (FDA) penalty has been higher for many global leaders, like GlaxoSmithKline (British) which signed a consent decree in 2005 to post a penal bond of $650 million for violation of manufacturing standards. In 2011, the FDA issued a consent decree to McNeil Consumer Healthcare, a Johnson & Johnson (US) subsidiary, over its repeated manufacturing problems (for drug Tylenol), indefinitely closing one plant and placing oversight over the two others. In another consent decree, Ben Venue Laboratories, a subsidiary of Boehringer Ingelheim (German), was restrained from manufacturing and distributing drugs from its Ohio facility until FDA determines that its operations are compliant with the Federal Food, Drug & Cosmetic Act. The loss of business and reputation is a greater risk than the penalty payable.
Does the closure of this case impact the Indian generic drug market?indian manufacturers
The consent decree puts a lid on the case. The company (Ranbaxy) can now start afresh and focus on its business. It is unlikely to have any spillover effect on other Indian companies. The US FDA processes are very objective and thorough, but unbiased. The fear of collateral damage is from the foreign competition. They may use this episode to contain the challenge of safe, affordable and quality generics from India.
What are the learnings Indian companies can take away from Ranbaxy’s issues with the FDA?
The first and most important lesson is not to compromise quality and safety of medicines. The second and more important lesson is not to cover up, even if the error is inadvertent. In this context, Johnson & Johnson’s response to owning up to the responsibility for manufacturing and quality defects in an over-thecounter drug Tylenol is noteworthy.
Has the case damaged the reputation of the Indian generic drug market, and Ranbaxy in particular? Will exports from other Indian companies gain from their disgrace?
One cannot rule out collateral damage by foreign competitors, but all Indian companies will have to work together to prevent such damage. After the consent decree, when the company (Ranbaxy) is able to resume supplies,indian manufacturer it is unlikely that other Indian companies can take away their business. Whatever was lost, was lost before the consent decree (was signed).
Falsification of data and violation of manufacturing process guidelines were charges leveled against Ranbaxy. Are those widespread problems in India?
Regulators from different jurisdictions have not come across such practices which confirm it is not a widespread problem.,indian suppliers
Cases of adulterated medicines have been reported from the Indian market as well. Why aren’t our norms as stringent as the FDA?
The National Drug Regulatory Authority is a product of the milieu. It evolves by national priority and is generally in conformity with the standards of general hygiene, sanitation and drinking water. India is moving towards improving these standards and has made significant progress in the last decade. However, we still have a long way to go. In the meantime, companies looking at the developed markets adopt appropriate standards to suit their business requirements.
In the US and other developed markets, there is a robust system of recalling all consumer goods, including medicines. What do we have in India?
Rules 54 and 55 of the Drugs & Cosmetics Act have provision for freezing and destroying stocks of sub-standard medicines. Rule 74(j) of the Act empowers the licensing authority and obliges the manufacturer to recall medicines not conforming to the standards.
Companies follow strict guidelines for the export of medicines. Why can’t they then abide by the same standards in their home market?
India does not have different standards for different markets. However, the manufacturers comply with the standards of the respective markets where they are selling their products. The h a r m o n i z at i o n o f standards is a major challenge. Political leadership and drug regulators need to work on it. Some progress is made under the ICH (Inter national Conference on Harmonization), but there is still a long way to go.
Weakening trade barriers boon for Indian agri biz
Monday, 12 August 2013
The Pope’s moral blunders on outsourcing
Automobile sales plunge to multi-year lows in Nov,Sector Bears The Brunt Of Economic Turmoil, Witnesses Major Downfall
Subscribe to:
Comments (Atom)